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Abbreviation:
TEa – Total error allowed
CVl – Coefficient of variation
Introduction
The haemogram is one of the most frequently requested laboratory tests, in hospital and ambulatory. Therefore, given its importance in the clinical context, an
evaluation was performed on the results of the clinical laboratories participating in PNAEQ’s EQA Cell Blood program. The main objective of this work was to
improve the Sigma quality level of the clinical laboratories and reduce the variability of their results.
Methods
The data used in this work is referred to the period from 2015 to 2017 and regarding each parameter, haemoglobin, platelets, leukocytes and erythrocytes, data
from 24 control samples, distributed 4 times per year, was collected. The samples used were purchased from an EQA provider of Europe, and most of the
samples were also used in the EQA program of that entity.
For the calculation of the Six Sigma metric, the inaccuracy (bias) associated to the result obtained by each laboratory for different parameters of each sample
was determined and the outlier’s treatment was performed. In the first approach, evaluation per sample, the Normality of each sample results was studied by
applying the Kolmogorov-Smirnov test [Sigma level = P (X ≥ X admissable bias) x 106]. The Box-Cox transformation was applied whenever necessary. Regarding
haemoglobin parameter, a second approach, namely the linear regression was applied to the results of 45 laboratories(1) [Sigma level= (TEa - Bias) / CVI]. This
model allows establishing a comparison between the laboratories’ results and the consensus value, obtained by the average of the participating laboratories. The
Sigma quality level for both approaches was obtained considering the desirable quality specification based on the biological variation(2).
Results and discussion
After the statistical analysis of the results, the mean Sigma quality level in the sample approach was 1.71 (Figure 1), 2.22 (Figure 2), 1.57 (Figure 3) and 1.95
(Figure 4) for the parameter platelets, leukocytes, erythrocytes and haemoglobin, respectively. The mean Sigma quality level obtained in the laboratory approach
for the parameter haemoglobin was 2.64 (Figure 5). Although the Sigma quality level ranged from 0.57 to 6.30, only 15 out of 45 laboratories had a Sigma quality
level above 3 (Figure 6).
Conclusion
Both approaches demonstrated a need to improve the analytical process performance. Therefore,
in brainstorming meetings with the participants were identified, in the Analyze phase, some
potential causes for the low performance. The most relevant causes consisted of the
homogenization of the control sample, absence of corrective actions resulting from the EQA
reports, control acceptance criteria and calibration of the equipment. Posteriorly, in the Improve
phase, improvement actions were elaborated and implemented. Through the pilot test, it was
possible to verify improvements in the analytical performance of the laboratories, obtaining a
Sigma quality level of 2.58, 2.27, 1.87 and 2.62, for the parameter, platelets, leukocytes,
erythrocytes and haemoglobin, respectively (Figure 7).
Continuous monitoring of the processes will be carried out, aiming to ensure that the implemented improvements continue to be practiced.
A comparison study between the participants of the European EQA Provider, should be carried out and performed the same sigma study.
Note:This study was presented in Labquality Days in 
February 2019.
